Schrodinger, Inc.
Recurring revenueRegulated industrySells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $25.66
- 52-Week Range
- $10.95 – $34.00
- Market Cap
- $2.04B
- P/E (TTM)
- —
- EPS (TTM)
- -0.79
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 6.76
- PEG Ratio
- —
- Return on Equity
- -19.02%
- Return on Assets
- -13.20%
- Gross Margin
- 58.52%
- Operating Margin
- -49.64%
- Profit Margin
- -22.01%
- Current Ratio
- 2.75
- Debt/Equity
- 0.35
- Total Debt
- $104.63M
- Free Cash Flow
- $-32.96M
- Revenue Growth
- 18.70%
- Earnings Growth
- —
- Enterprise Value
- $1.78B
Market Snapshot
About
Schrodinger, Inc. is a life sciences software and drug discovery company that develops physics-based computational platforms for drug discovery and materials design. The company platform is used by pharmaceutical and biotechnology companies, as well as academic and government laboratories worldwide.